logo-loader
NASDAQ:BIIB ETR:IDP

Biogen Inc

Receive alerts
Market:
NASDAQ
Price
214.97 USD
Day Change
-0.63%
Market Cap:
$31.24 b
52 weeks high
319.76
52 weeks low
211.10

In brief

Biogen Inc is a leading global biotechnology company that has pioneered multiple breakthrough innovations including a broad portfolio of medicines to treat multiple sclerosis, the first approved treatment for spinal muscular atrophy, and two co-developed treatments to address a defining pathology of Alzheimer’s disease, the first treatment to target a genetic form of ALS, the first oral treatment approved for postpartum depression, and the first approved treatment for Friedreich’s ataxia.